Life Technologies Announces Expansion of TaqMan® Mutation Detection Assays

CARLSBAD, Calif.,-- Life Technologies Corporation today announced the expansion to its TaqMan® Mutation Detection Assays -- highly sensitive and novel molecular analysis research tools designed to detect an additional 241 of the most common mutations in 21 cancer genes. The TaqMan® Mutation Detection Assays can screen for extremely minute levels of mutations in heterogenous samples [...]

Biotage Unveils Isolera (TM) Spektra with Full PDA Spectral Scanning

Uppsala, Sweden,-- Biotage® (STO: BIOT), a leading global supplier of solutions and technology for analytical and medicinal chemistry, introduced Isolera™ Spektra. The new Isolera™ Spektra expands the scope of application of Biotage’s market-leading Flash Chromatography product line by increasing efficiency with significant solvent and time saving capabilities as well as enabling purity assessment technology. The [...]

BioScale Presents Data from a Novel Signal Transduction Pathway Analysis Using AMMP Assays at the 2012 American Association of Cancer Research (AACR) Meeting

BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, presented findings of recently completed research studies on phospho-protein analysis of the activation state of the MAP kinase pathway at the 103rd Annual Meeting of the American Association for Cancer Research (AACR), held at McCormick Place in Chicago, Illinois, March 31 - April [...]

Life Technologies Showcases Leading Technologies for Cancer Research at the AACR Annual Meeting 2012

CARLSBAD, Calif.,-- Life Technologies Corporation (NASDAQ: LIFE) will exhibit products across the spectrum of basic, translational and clinical cancer research during the American Association of Cancer Research (AACR) Annual Meeting 2012, taking place March 31 – April 4, in Chicago, Illinois. In addition, several of Life's customers and collaborators will present research findings. "From basic [...]

ENZO BIOCHEM PRESENTS NEW AMPIPROBE™ NUCLEIC ACID AMPLIFICATION PLATFORM DETAILS AT ESCMID LONDON MEETING

NEW YORK, NY,– Enzo Biochem Inc.announced that the Company yesterday made its first peer-reviewed presentation of its novel AmpiProbe™ platform, encompassing low cost, and high sensitivity, real time nucleic acid amplification and detection assays, at the annual meeting in London of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). The Company’s presentation, titled [...]

Bruker and University Medical Center Groningen (UMCG) Announce a Collaboration within new European Network for Rapid Identification of Anaerobes (ENRIA)

LONDON -- At the 22nd ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) in London, Bruker announces a collaboration with UMCG within the new European Network for the Rapid Identification of Anaerobes (ENRIA), based on Bruker´s MALDI Biotyper system for MALDI-TOF mass spectrometry-based microbial identification. Anaerobic infections belong to the neglected infectious diseases and [...]

VICAM’s New Fumo-V Strip Tests Delivers Accurate Detection of Fumonisin Mycotoxins in Minutes New Simple and Quantitative Test Extends Value and Utility of Vertu Lateral Flow Reader

MILFORD, Mass.,-- The Waters Corporation today announced VICAM®, a Waters® Business, introduced the Fumo-V™ strip test, the newest member of its quantitative strip test family. Designed to work with the portable Vertu™ Lateral Flow Reader, Fumo-V uses the proven sensitivity and selectivity of VICAM's monoclonal antibodies to accurately detect and measure fumonisin B1, B2, and [...]

Asuragen awarded $6.8 million commercialization award from the Cancer Prevention and Research Institute of Texas

Austin, Texas – Asuragen, Inc. announced today that the Company received notice of a $6.8 million commercialization award to pursue Next Generation Sequencing (NGS) applications from the State of Texas through the Cancer Prevention and Research Institute of Texas (“CPRIT”). CPRIT was established to expedite innovation and commercialization in the area of cancer research and [...]

CAMO Software Partners with Optimal Industrial Automation Ltd to Offer Multivariate Data Analysis in the synTQ® Lite Software for PAT Environments

The partnership enables CAMO Software’s Unscrambler® X multivariate analytical engines to be offered together with Optimal’s synTQ® Lite software, designed for PAT (Process Analytical Technology) environments in the life sciences industry. CAMO Software CEO, Paal Braathen, says, ”We are very pleased to be working more closely with Optimal, an established leader in process automation. Our [...]

NanoString Introduces Three New Products at AACR Annual Meeting

SEATTLE, Wash. – NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it will launch three new products for the nCounter® Analysis System at the American Association of Cancer Research (AACR) Annual Meeting 2012, March 31-April 4, in Chicago, Ill. NanoString’s suite [...]

Access IBO on Knowledge Center